An October 2019 article in USA Today focused on how critical it is that opioid lawsuit settlement dollars are used to treat addiction. This should be a given, to use settlements from pharma companies to treat addicts (especially considering that many addicts would not be addicts were it not for prescription painkillers).
Within the opioid addiction epidemic in this country, several types of drugs play a role. But opiates take the lead for causing the most harm, for taking the most lives, and for creating the largest public health burden.
In July 2019, Pharmaceutical company Reckitt Benckiser Group settled a federal lawsuit that they fraudulently marketed their addiction treatment drug Suboxone. They’ll pay a huge fine but why doesn’t this settlement actually result in justice?
In August 2019, Cleveland County Judge Thad Balkman ordered Johnson & Johnson and their subsidiary, Janssen Pharmaceuticals to pay Oklahoma $572 million for the harm their products cause. When the settlement is paid, what will the benefits actually be? Will Oklahomans actually benefit?
There’s something special and even a little energizing when the bad guy finally gets caught. When the underdog hero somehow manages to win against insurmountable odds.
Many of us silently cheer when we hear about a mega-corporation losing a lawsuit against an underdog. This particular aspect of human nature is evidenced in Hollywood films, music, books, pop culture, and bedtime stories.
After working with hundreds of people who struggled with addiction over the last eight years, I’ve often wondered if our country’s drug problem has an end in sight. I’ve seen addiction in my fellow man in one form or another all my life.
How Modern-Day Marketing Makes Good People into Addicts The United States is a unique country in a lot of ways. We are the land of the free, the home of the brave. But there is one area in which we are quite trapped.
Researchers may have found a medication that might alleviate the withdrawal symptoms resulting from marijuana addiction. Is this a useful medication? We break down the answer point by point.
According to a Washington Post article published February 2015, the United States and New Zealand are the only two countries that allow direct to consumer advertising for pharmaceutical products.